Claire Entwisle

A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease

M. E. G. Boursnell, Claire Entwisle, D M Blakeley et al. · The Journal of Infectious Diseases · 1997 · 158 citations · Full text

Veterinary Vaccine, Immunology, Pathology +16

A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.

Molly Browne, J.E. Carey, C.G. Chapman et al. · Journal of Biological Chemistry · 1988 · 88 citations · Full text

Induction of Anti-Mammary Cancer Immunity by Engaging the OX-40 Receptor in Vivo

Arden M. Morris, John T. Vetto, Trygg Ramstad et al. · Breast Cancer Research and Treatment · 2001 · 78 citations

Ox-40 Receptor, Anti-mammary Cancer Immunity, Immunology +8

Anti-tumour therapeutic efficacy of OX40L in murine tumour model

Selman Ali, Murrium Ahmad, June Lynam et al. · Vaccine · 2004 · 58 citations

Tumor Biology, Medicine, Pharmacology +6

Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial

Claire Entwisle, Sue Hill, Yin Pang et al. · Vaccine · 2017 · 40 citations

Vaccinology, Vaccination, Vaccine Safety +8